Clinical Trial Update: A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 4]

View source ↗

Summary

Phase 4 randomized, double-blind trial comparing placebo and atomoxetine once daily in adults with attention-deficit/hyperactivity disorder; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED | Results posted: 2010-10-21